Barclays PLC purchased a new position in shares of Monogram Orthopaedics, Inc. (NASDAQ:MGRM – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,897 shares of the company’s stock, valued at approximately $29,000.
Separately, State Street Corp purchased a new position in shares of Monogram Orthopaedics in the 3rd quarter worth $62,000. 0.45% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several research analysts recently weighed in on MGRM shares. Roth Mkm started coverage on Monogram Orthopaedics in a research report on Monday, December 9th. They issued a “buy” rating and a $4.00 target price on the stock. Roth Capital raised Monogram Orthopaedics to a “strong-buy” rating in a research report on Monday, December 9th.
Monogram Orthopaedics Stock Performance
Shares of NASDAQ MGRM opened at $2.50 on Friday. Monogram Orthopaedics, Inc. has a 12-month low of $1.53 and a 12-month high of $4.90. The company has a market cap of $85.78 million, a P/E ratio of -5.32 and a beta of 1.51. The stock has a fifty day moving average price of $2.34 and a 200 day moving average price of $2.46.
Monogram Orthopaedics Company Profile
Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
Recommended Stories
- Five stocks we like better than Monogram Orthopaedics
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Following Congress Stock Trades
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Which Wall Street Analysts are the Most Accurate?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding MGRM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monogram Orthopaedics, Inc. (NASDAQ:MGRM – Free Report).
Receive News & Ratings for Monogram Orthopaedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monogram Orthopaedics and related companies with MarketBeat.com's FREE daily email newsletter.
